PNPLA3 and metabolic dysfunction-associated steatotic liver disease: These findings aligned well with our findings on steatosis induction following PNPLA3 KO in WT organoids (Fig. 1d–f), and suggested FatTracer’s potential in evaluation of NAFLD risk genes.